ClinicalTrials.govpublic full text
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1
chronic hepatitis c genotype 1, hepatitis, hcv, antiviral, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968327
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.